The success of Cleveland Clinic Innovations has triggered a puzzling dilemma for the world-renowned health system: how to manage the windfall of its leader.
Innovations’ Executive Director Chris Coburn gets 3 percent from the sale of spinoff companies, according to several sources familiar with Coburn’s contract – including one who has personally reviewed Coburn’s deal. The implication of that number became clear after Boston Scientific bought Cleveland Clinic spinoff Intelect Medical for $78 million.
To read the full, original article click on this link: Cleveland Clinic, Chris Coburn’s big payoff (and challenge): $840,000
Author: Brandon Glenn
